pembrolizumab,vibostolimab,favezelimab
merck
['mibc', 'pembro', 'key,note,57', 'nmibc', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', ' teva ']
latest data from keynote057 cohort b for pembro in bcg-unresponsive nmibc by pembro could be. a reasonable option for ots not fit/refusing cystectomy.
#gu23 
GU oncologist, clinical trialist, Director GU Oncology @CleclinicMD Tweets my own, RT/Likes not active endorsement.